These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 3904885)

  • 1. Sulpiride and haloperidol in schizophrenia: a double-blind cross-over study of therapeutic effect, side effects and plasma concentrations.
    Gerlach J; Behnke K; Heltberg J; Munk-Anderson E; Nielsen H
    Br J Psychiatry; 1985 Sep; 147():283-8. PubMed ID: 3904885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical and pharmacodynamic evaluation of sulpiride.
    Rao VA; Bailey J; Bishop M; Coppen A
    Psychopharmacology (Berl); 1981; 73(1):77-80. PubMed ID: 6785794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulpiride versus haloperidol, a clinical trial in schizophrenia. A preliminary report.
    Munk-Andersen E; Behnke K; Heltberg J; Nielsen H; Gerlach J
    Acta Psychiatr Scand Suppl; 1984; 311():31-41. PubMed ID: 6367362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulpiride--an antipsychotic agent: comparative trial vs. haloperidol.
    Cassano GB; Castrogiovanni P; Conti L; Bonollo L
    Psychopharmacol Bull; 1977 Jul; 13(3):41-3. PubMed ID: 18759
    [No Abstract]   [Full Text] [Related]  

  • 5. Amisulpride versus haloperidol in treatment of schizophrenic patients--results of a double-blind study.
    Delcker A; Schoon ML; Oczkowski B; Gaertner HJ
    Pharmacopsychiatry; 1990 May; 23(3):125-30. PubMed ID: 1973843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulpiride versus haloperidol in schizophrenia: a double-blind comparative trial.
    Cassano GB; Castrogiovanni P; Conti L; Bonollo L
    Curr Ther Res Clin Exp; 1975 Feb; 17(2):189-201. PubMed ID: 234359
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of positive and negative symptoms: pharmacologic approaches.
    Boyer P; Lecrubier Y; Puech AJ
    Mod Probl Pharmacopsychiatry; 1990; 24():152-74. PubMed ID: 1970852
    [No Abstract]   [Full Text] [Related]  

  • 8. Controlled trial of sulpiride in chronic schizophrenic patients.
    Edwards JG; Alexander JR; Alexander MS; Gordon A; Zutchi T
    Br J Psychiatry; 1980 Dec; 137():522-9. PubMed ID: 7011469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single-blind comparison of bromperidol and sulpiride in hospitalized schizophrenics.
    Yamagami S; Hirayama E; Mui K; Okuno M; Kioka T; Soma T; Ohno K
    Acta Psychiatr Belg; 1993; 93(4):236-44. PubMed ID: 7913572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remoxipride and haloperidol in schizophrenia: a double-blind multicentre study.
    Ahlfors UG; Rimön R; Appelberg B; Hagert U; Harma P; Katila H; Mahlanen A; Mehtonen OP; Naukkarinen H; Outakoski J
    Acta Psychiatr Scand Suppl; 1990; 358():99-103. PubMed ID: 1978501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma concentrations of remoxipride and haloperidol in relation to prolactin and short-term therapeutic outcome in schizophrenic patients.
    Lahdelma RL; Appelberg B; Kuoppasalmi K; Katila H; Rimón R
    Eur Neuropsychopharmacol; 1991 Dec; 1(4):535-40. PubMed ID: 1688013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amisulpride: efficacy in the management of chronic patients with predominant negative symptoms of schizophrenia.
    Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2001 Oct; 251(5):217-24. PubMed ID: 11829208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations.
    Alfredsson G; Härnryd C; Wiesel FA
    Psychopharmacology (Berl); 1985; 85(1):8-13. PubMed ID: 3920702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
    Möller HJ; Riedel M; Jäger M; Wickelmaier F; Maier W; Kühn KU; Buchkremer G; Heuser I; Klosterkötter J; Gastpar M; Braus DF; Schlösser R; Schneider F; Ohmann C; Riesbeck M; Gaebel W
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of sulpiride in schizophrenic patients--a double-blind comparison with chlorpromazine.
    Härnryd C; Bjerkenstedt L; Björk K; Gullberg B; Oxenstierna G; Sedvall G; Wiesel FA; Wik G; Aberg-Wistedt A
    Acta Psychiatr Scand Suppl; 1984; 311():7-30. PubMed ID: 6367364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol].
    Barnas C; Stuppäck CH; Miller C; Haring C; Sperner-Unterweger B; Fleischhacker WW
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():36-40. PubMed ID: 1683338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical profile of remoxipride--a combined analysis of a comparative double-blind multicentre trial programme.
    Lewander T; Westerbergh SE; Morrison D
    Acta Psychiatr Scand Suppl; 1990; 358():92-8. PubMed ID: 1978500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sulpiride and chlorpromazine on depressive symptoms in schizophrenic patients--relationship to drug concentrations.
    Alfredsson G; Härnryd C; Wiesel FA
    Psychopharmacology (Berl); 1984; 84(2):237-41. PubMed ID: 6438683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine.
    Alfredsson G; Bjerkenstedt L; Edman G; Härnryd C; Oxenstierna G; Sedvall G; Wiesel FA
    Acta Psychiatr Scand Suppl; 1984; 311():49-74. PubMed ID: 6199949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of serum haloperidol levels to clinical response in schizophrenic patients.
    Magliozzi JR; Hollister LE; Arnold KV; Earle GM
    Am J Psychiatry; 1981 Mar; 138(3):365-7. PubMed ID: 7468835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.